Stock Market Reviews

NSRX (Nasus Pharma Ltd.) News

Get the latest news, insights, and market updates on NSRX (Nasus Pharma Ltd.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Nasus Pharma Marks NYSE American Listing with Bell Ringing Ceremony
  TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, proudly announced today that it had the honor of ringing the Closing Bell on Monday, 25 August, 2025, at the New York Stock Exchange (“NYSE”). This prestigious event marked a significant milestone in the Company’s journey to transform emergen
  Aug 26, 2025 - $NSRX
• Nasus Pharma Announces Closing of Initial Public Offering
  TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced the closing of its initial public offering of 1,250,000 ordinary shares (“Ordinary Shares”) at a public offering price of $8.00 per Ordinary Share. The gross proceeds of the offering were $10 million, prior to deducting underw
  Aug 14, 2025 - $NSRX
• Nasus Pharma Announces Pricing of $10 Million Initial Public Offering
  TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced the pricing of its initial public offering of 1,250,000 ordinary shares (“Ordinary Shares”) at a public offering price of $8.00 per Ordinary Share, for aggregate gross proceeds of $10 million, prior to deducting underwriting d
  Aug 13, 2025 - $NSRX